NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001175

Registered date:01/07/2008

analysis of immunocytes in patients with brain tumor treated with temozolomide

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedbrain tumor
Date of first enrollment2007/03/01
Target sample size20
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeWe collect blood from the patients before taking temozolomide, after 3 and 6 weeks after taking temozolomide, and every 4-8 weeks after that. We extract the lymphocyte of the blood and analyze the immunocytes including WT1 peptide-specific CD8-positive killer T-cell.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriano

Related Information

Contact

public contact
Name Chiba Yasuyoshi
Address Japan
Telephone 06-6879-3652
E-mail ychiba@nsurg.med.osaka-u.ac.jp
Affiliation Osaka University Graduate School of Medicine Department of Neurosurgery
scientific contact
Name Toshiki Yoshmine
Address 2-2 Yamada-oka, Suita-city, Osaka, Japan Japan
Telephone 06-6879-3652
E-mail
Affiliation Osaka University Graduate School of Medicine Department of Neurosurgery